Medication adherence program: Adherence challenges and interventions in type 2 diabetes

Journal of the American Pharmacists Association

Volumn 53, Issue 3, 2013, Pages 267-272

  Odegard, Peggy Soule ^a   Carpinito, Gina ^a   Christensen, Dale B ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Adherence (medication); Community pharmacy; Diabetes; Interventions

Indexed keywords

ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; DIABETES EDUCATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACIST; PRESCRIPTION; SELF CARE; TELECOMMUNICATION; URBAN POPULATION;

EID: 84890068125     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2013.12065     Document Type: Article

References (11)

1. Sclar DA, Robison LM, Skaer TL, et al. Sulfonylurea pharmacotherapy regimen in a Medicaid population: influence of age, gender, and race. Diabetes Educ. 1999;25(4):531-8.
2. Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care. 1997;20(10):1512-7.
3. Raebel MA, Carroll NM, Ellis JL, et al. Importance of including early nonadherence in estimations of medication adherence. Ann Pharmacother. 2011;45(9):1053-60.
4. Shah NR, Hirsch AG, Zacker C, et al. Factors associated with first-fill adherence rates for diabetic medications: a cohort study. J Gen Intern Med. 2009;24(2):233-7.
5. Hertz RP, Unger AN, Lustik MB. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther. 2005;27(7):1064-73.
6. Odegard PS, Christensen DB. MAP study: RCT of a medication adherence program for patients with type 2 diabetes. J Am Pharm Assoc. 2012;52(6):753-62.
7. Odegard PS, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ. 2008;34(4):692-7.
8. Christensen DB, Neil N, Fassett WE, et al. Frequency and characteristics of cognitive services provided in response to a financial incentive. J Am Pharm Assoc. 2000;40(5):609-17.
9. Christensen DB, Hansen RW. Characteristics of pharmacies and pharmacists associated with the provision of cognitive services in the community setting. J Am Pharm Assoc. 1999;39(5):640-9.
10. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28(4):421-36.
11. Look KA, Mott DA, Leedham RK, et al. Pharmacy participation and claim characteristics in the Wisconsin Medicaid Pharmaceutical Care Program from 1996 to 2007. J Manag Care Pharm. 2012;18(2):116-28.